Develco Pharma Schweiz Ag Is A Pharmaceutical Company Based In Prattelnswitzerlandfounded In 2006 By Mathias Scheerthe Company Specializes In The Developmentmanufacturingand Licensing Of Complex Drug Formulationsparticularly Focusing On Modified And Delayed Release Technologies To Enhance Patient Quality Of Life Develco Offers A Range Of Servicesincluding The Development Of Advanced Drug Formulationscontract Manufacturing At A State Of The Art Facility In Germanyand Lifecycle Management In Collaboration With International Pharmaceutical Companiestheir Portfolio Includes Products Aimed At Severe Pain Management And Adhd Treatmentwith Expertise In Nmda Receptor Modulatorsthe Company Emphasizes Small Molecule Drugs And Aims To Provide Cost Effective Generic Alternatives To Improve Global Medicine Accessibility With A Commitment To Reducing Healthcare Disparitiesdevelco Integrates Modern Technologies For Project Management And Quality Controlthey Maintain Full Control Over The Value Chainfrom Development To Deliveryand Partner With Global Firms For Product Licensing And Distributionthe Company Employs Between 201 And 500 Staff And Prioritizes Sustainability And Innovation In Its Operations
